Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Details on Person Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases

Class:Id	LiteratureReference:9766101
_displayName	Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases
_timestamp	2022-02-17 21:08:46
author	[Person:9761944] Cuadrado, Antonio [Person:9761949] Rojo, Ana I [Person:9766106] Wells, Geoffrey [Person:5432693] Hayes, John D [Person:9766104] Cousin, Sharon P [Person:9704048] Rumsey, William L [Person:9766103] Attucks, Otis C [Person:9766105] Franklin, Stephen [Person:9708487] Levonen, Anna-Liisa [Person:5432688] Kensler, Thomas W [Person:8932298] Dinkova-Kostova, Albena T
created	[InstanceEdit:9766102] Rothfels, Karen, 2022-02-17
journal	Nat Rev Drug Discov
pages	295-317
pubMedIdentifier	30610225
title	Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases
volume	18
year	2019
(literatureReference)	[Reaction:8952630] NEDD8:AcM-UBE2M binds CRL3 E3 ubiquitin ligase complex [Homo sapiens] [Reaction:9712274] NFE2L2 inducers bind to KEAP1:CUL3:RBX1:NFE2L2 [Homo sapiens] [Pathway:9755511] KEAP1-NFE2L2 pathway [Homo sapiens]
[Change default viewing format]

No pathways have been reviewed or authored by Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases (9766101)